Sickle cell disease: open trials in Spain

12 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT06975865
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Trial Treatment · Phase 3 · Sanofi
Madrid · Madrid
Registry updated 2026-10-15
NCT06699849
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Trial Treatment · Phase 2 · CSL Behring
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Sant Joan De Deu Barcelona, Esplugues de Llobregat · Hospital General Universitario Gregorio Marañón, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-10-08
2025-524464-38-00
A research study to evaluate how well etavopivat works in children with sickle cell disease
Trial Treatment · Phase 3 · Novo Nordisk A/S
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario La Paz, Madrid · Hospital Universitario Miguel Servet, Zaragoza
Registry updated 2026-09-28
NCT06609226
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Trial Treatment · Phase 3 · Novo Nordisk A/S
Hospital Universitario de Cruces, Barakaldo · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario La Paz, Madrid
Registry updated 2026-09-18
NCT06612268
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Trial Treatment · Phase 3 · Novo Nordisk A/S
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca, Barcelona · Hospital Universitario La Paz, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-09-17
NCT05431088
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Trial Treatment · Phase 2/3 · Pfizer
Hospital Universitario de Cruces, Barakaldo · Hospital Universitari Vall d'Hebron, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario La Paz, Madrid
Registry updated 2026-08-18
2025-521838-29-00
Study of IADADEMSTAT for the Treatment of Sickle Cell Disease.
Trial Treatment · Phase 1 · Oryzon Genomics S.A.
Institut Catala d'Oncologia, Badalona · Hospital Clinic Barcelona, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario La Paz, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-07-17
NCT04657822
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Vall d'Hebron Institute of Oncology, Barcelona · Hospital General Universitario Gregorio Marañón, Madrid
Registry updated 2026-06-08
NCT07206095
Integrative Diagnosis for SCD and Other RADs
Research · Hospital Universitari Vall d'Hebron Research Institute
Hospital Universitari Vall d'Hebron, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Sant Joan De Deu, Esplugues de Llobregat · Hospital General de Granollers, Granollers · Hospital Universitari Arnau de Vilanova, Lleida · Consorci Sanitari del Maresme - Hospital de Mataró, Mataró · Parc Tauli Hospital Universitari, Sabadell · Consorci Sanitari de Terrassa, Terrassa · Hospital Universitari Mútua de Terrassa, Terrassa
Registry updated 2025-10-03
NCT05799118
Study of the Role of Genetic Modifiers in Hemoglobinopathies
Research · Cyprus Institute of Neurology and Genetics
Hospital Clínico San Carlos, Madrid
Registry updated 2024-03-20
NCT06250595
European Rare Blood Disorders Platform (ENROL)
Research · Hospital Universitari Vall d'Hebron Research Institute
María del Mar, Barcelona
Registry updated 2024-02-09
NCT06213402
RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs)
Research · Hospital Universitari Vall d'Hebron Research Institute
Vall d'hebron Research Institute - Vall d'Hebron Research Institute - University Hospital Vall d'Hebrón (VHIR/HUVH), Barcelona
Registry updated 2024-01-19

All Sickle cell disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error